| RS1556421658 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1556421731 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS1556422499 |
MT-RNR1
|
Health Risk |
Pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS1556423388 |
MT-CO2
|
Health Risk |
Likely pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS1556423632 |
MT-ATP6
|
Health Risk |
Likely pathogenic |
Leigh syndrome, Mitochondrial disease |
| RS1556423703 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1556423728 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1556423844 |
MT-ND4L
|
Health Risk |
Likely pathogenic |
Leber optic atrophy, Mitochondrial disease |
| RS1556424691 |
MT-TT
|
Health Risk |
Likely pathogenic |
Variant of unknown significance, 7 conditions |
| RS1556425186 |
SBF1
|
Health Risk |
Pathogenic |
— |
| RS1556425300 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1556425467 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1556425468 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Bethlem myopathy 1A |
| RS1556425474 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1556425531 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1556425566 |
COL6A1
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1556425596 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Ullrich congenital muscular dystrophy 1A |
| RS1556425679 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1556425687 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1556425717 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1556425832 |
COL6A1
|
Health Risk |
Pathogenic |
— |
| RS1556425835 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1556425853 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1556435929 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS1556435940 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS1556436706 |
SBF1
|
Health Risk |
Pathogenic |
— |
| RS1556436855 |
SBF1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4B3, Charcot-Marie-Tooth disease type 4B3 |
| RS1556437035 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS1556439394 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1556446493 |
COL4A5
|
Health Risk |
Pathogenic |
Chronic kidney disease, Elevated mean arterial pressure |
| RS1556446657 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS1556450491 |
XK
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1556450972 |
SHOX
|
Health Risk |
Pathogenic |
SHOX-related short stature, SHOX-related short stature |
| RS1556451235 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1556453243 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1556453276 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1556462917 |
COL4A5
|
Health Risk |
Likely pathogenic |
Lung cancer, X-linked Alport syndrome |
| RS1556463583 |
COL4A5
|
Health Risk |
Likely pathogenic |
Proteinuria, Hematuria |
| RS1556464116 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1556464542 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS1556464554 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1556464581 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1556464851 |
CYBB
|
Health Risk |
Conflicting classifications of pathogenicity |
Granulomatous disease, chronic |
| RS1556464882 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS1556468360 |
CYBB
|
Health Risk |
Likely pathogenic |
— |
| RS1556468363 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS1556468777 |
SHOX
|
Health Risk |
Pathogenic |
— |
| RS1556469197 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1556470775 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1556470794 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS1556471620 |
CYBB
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS1556472628 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS1556473078 |
CYBB
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS1556473119 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1556483060 |
SCO2
|
Health Risk |
Likely pathogenic |
— |
| RS1556483387 |
ALG13
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 36 |
| RS1556486029 |
TYMP
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 1, Mitochondrial DNA depletion syndrome 1 |
| RS1556486467 |
TYMP
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 1, Mitochondrial DNA depletion syndrome 1 |
| RS1556488264 |
TYMP
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 1, Mitochondrial DNA depletion syndrome 1 |
| RS1556488369 |
TYMP
|
Health Risk |
Pathogenic |
— |
| RS1556503812 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1556503937 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1556516921 |
ALG13
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 36 |
| RS1556518231 |
SOX3
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked |
| RS1556526609 |
DEPDC5
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial focal epilepsy with variable foci, Melanoma |
| RS1556539065 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1556553319 |
STAG2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1556586479 |
PEX26
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder 7A (Zellweger) |
| RS1556589033 |
PEX26
|
Health Risk |
Likely pathogenic |
— |
| RS1556590594 |
PEX26
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS1556607762 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS1556608580 |
DEPDC5
|
Health Risk |
Likely pathogenic |
— |
| RS1556617455 |
SLC9A6
|
Health Risk |
Pathogenic |
Christianson syndrome, Thyroid cancer |
| RS1556619319 |
SH2D1A
|
Health Risk |
Likely pathogenic |
X-linked lymphoproliferative disease due to SH2D1A deficiency, X-linked lymphoproliferative disease due to SH2D1A deficiency |
| RS1556620027 |
SLC9A6
|
Health Risk |
Pathogenic |
— |
| RS1556620697 |
SH2D1A
|
Health Risk |
Likely pathogenic |
X-linked lymphoproliferative disease due to SH2D1A deficiency, X-linked lymphoproliferative disease due to SH2D1A deficiency |
| RS1556620698 |
SH2D1A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1556620706 |
SH2D1A
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to SH2D1A deficiency, X-linked lymphoproliferative disease due to SH2D1A deficiency |
| RS1556635817 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1556638935 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS1556639109 |
FHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS1556639151 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS1556639352 |
FHL1
|
Health Risk |
Pathogenic |
Uruguay Faciocardiomusculoskeletal syndrome, Thyroid cancer |
| RS1556639379 |
FHL1
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS1556639771 |
FHL1
|
Health Risk |
Likely pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS1556641290 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1556642578 |
MYH9
|
Health Risk |
Likely pathogenic |
— |
| RS1556656077 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1556656184 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1556656298 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1556656456 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1556656487 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1556656767 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1556656818 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1556656847 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1556656851 |
DMD
|
Health Risk |
Pathogenic |
Dystrophin deficiency, Duchenne muscular dystrophy |
| RS1556656895 |
DMD
|
Health Risk |
Likely pathogenic |
— |
| RS1556665052 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1556665303 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1556669808 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |